2020~NOW

• 2024Cowell International Conference held (Seoul, South Korea)
  
  Awarded the Consumer Satisfaction Award (Dental Medical Devices - Implant Category)
  
  Dental Newspaper Advertising Award (Excellence in Academic Category)
  
  
• 2023Cowell International Conference held (Rome, Italy)
  
  First-ever publication of BMP-2 book (Lead author: Professor Jeong Eui-Won, Department of Periodontology, Yonsei University College of Dentistry)
  
  Actor Lee Kyung-Young (1960) and Im Hyun-Tae selected as advertising models
• 2022Launched SFIT Cementless Solution prosthetic system (Spread Fit)
• 2021Obtained Vietnam’s approval and certification for INNO Impalnt System and Cowell BMP.
  Obtained Medical Device License in Canada (Health Canada).
  
  Obtained China’s approval and certification for INNO Impalnt System (NMPA).
• 2020Obtained MDSAP (Medical Device Single Audit Program) certification (TUV).
  
  Global Hidden Champion by Ministry of SMEs.

2010~2019

• 2019Launched bone carrier for all procedures ’InnoGenic™ Bone Carrier’.
  
  Held ‘COWELL® International Conference’ in Jeju, Korea.
  Certified as ‘Intellectual Property Management Enterprise’.
  
  Launched non-resorbable membrane ‘InnoGenic™ Wifi-Mesh’.
  
  Launched autobone harvesting kit ‘InnoGenic™ Autobone Harvester’.
  
  Selected as Global IP(Intellectual Property) Star Corporate
  (Regional Intellectual Property Center).
  
  Launched world’s first Beauty UP Implant.
  Launched world’s first Volume UP Implant.
• 2018Held ‘COWELL® International Conference’ in Prague, Czech Republic.
  
  Held “Global Forum in Seoul”.
  
  Launched Hurricane Bone Collector.
• 2017Held ‘COWELL® International Conference’ in Bangkok, Thailand.
  
  Established overseas corporation in China and Taiwan.
• 2016Held ‘COWELL® International Conference’ in Seoul, Korea.
  
  Launched INNO-CaP which bone graft material consist of Calcium Phosphate.
• 2015Held ‘COWELL® International Conference’ in Barcelona, Spain.
  
  Earned approval for Mini Plus SLA Fixture as a manufactured product item(MFDS).
• 2014Completed the development of Bioactive surface treatment technology.
  
  Held ‘COWELL® International Conference’ in Seoul, Korea.
  
  Registered a domestic patent for the implant kit consisting of titanium implants and growth factors.
  
  Registered a domestic patent for the tissue or organ regeneration kit including growth factors and membranes and scaffolds.
  Earned India’s approval and certification for INNO SLA Sub. Implant
  (CDSCO; Central Drugs Standard Control Organization).
• 2013Obtained USFDA approval for INNO SLA Implant System (Sub.).
  
  Selected as a KBSI(Korea Basic Science Institute) Partner Company.
• 2012Obtained a CE Certification for INNO SLA Implant.
  
  Launched INNO SLA Implant.
  
  Obtained approval for rhBMP-2 bone graft material(COWELLBMP) spinal fusion clinical test plan (MFDS).
• 2011Registered US patent for rhBMP-2 Coated Implant.
• 2010Obtained medical device manufacturing approval for rhBMP-2 bone graft material(COWELLBMP)
  (MFDS; Ministry of Food and Drug Safety).

2000~2009

• 2009Obtained approval for clinical test plan for rhBMP-2 bone graft material(COWELLBMP)
  (MFDS; Ministry of Food and Drug Safety).
• 2008Completed clinical trials for rhBMP-2 bone graft material(COWELLBMP)
  (Korea University Guro Hospital, Seoul National University Bundang Hospital).
  
  Began selling rhBMP-2 research reagents.
  Developed and began selling Sinus Lift Kit.
  Launched the sales of its products for training North Korean dentists
  (Dental Implant Products, Surgical Kits and Dental Engines).
• 2007Opened Seoul Branch and launched direct sales operation.
  
  Obtained a patent for rhBMP-2 Coated Implant.
  
  Applied for a US patent for rhBMP-2 Coated Implant.
• 2006Selected as an Excellent Entrepreneur (Busan Metropolitan City).
  Selected as a Leading Company in a Strategic Industry (Busan Metropolitan City).
  
  Received the Excellent Venture Entrepreneur Award (Busan Metropolitan City).
  Established Cowellmedi Tissue Engineering Institute for Growth Factors.
  
  Designated as a Family Firm (IBK; Industrial Bank if Korea).
• 2005Obtained ISO13485 Certificate.
  
  Obtained a GMP Certificate (KGMP; Korea Good Manufacturing Practice).
• 2004Established R&D Center.
  Received an Excellent Small & Medium Business Award (SMBA).
  CEO Dr. Soohong Kim D.D.S. Ph.D received the Bronze Tower Order of Industrial.
  Service Merit at the 5th Innovative Technology Show.
  Obtained USFDA approval for BIOPLANT Implant System.
  
  Selected as a Superior Technology Company (KTFC; The Korea Technology Finance Corporation).
  
  Received an Excellent Small & Medium Business Award (SMBA).
• 2003Selected as an INNOBIZ Company (SMBA).
  
  Selected as an Export-oriented Company (SMBA).
• 2002Selected as a Promising Export Firm (SMBA).
• 2001Selected as an Innovative Technology Development Company (SMBA).
• 2000Designated as a Venture Company (SMBA).
  
  Selected as a Promising Export Firm (SMBA; Small & Medium Business Administration).
  
  Obtained ISO-9001 Certification.
  
  Converted Corporation to COWELLMEDI Co., Ltd.

1994~1999

• 1999Entered an industrial-academic cooperation agreement with Pusan National University’s Oral and Biotechnology Research Center.
  
  Obtained medical device manufacturing license(MFDS; Ministry of Food and Drug Safety).
  Obtained medical device manufacturing approval for its BIOPLANT Implant System (MFDS).
• 1998Asrahi Medical founded (CEO : Soohong Kim D.D.S. Ph.D).
• 1994Successfully developed localization dental implants for the first time in Korea (Soohong Kim D.D.S. Ph.D).